2019
DOI: 10.1038/s41598-019-38981-1
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic Imaging of Glucose and Lactate Metabolism by 13C-MRS without Hyperpolarization

Abstract: Metabolic reprogramming is one of the defining features of cancer and abnormal metabolism is associated with many other pathologies. Molecular imaging techniques capable of detecting such changes have become essential for cancer diagnosis, treatment planning, and surveillance. In particular, 18 F-FDG (fluorodeoxyglucose) PET has emerged as an essential imaging modality for cancer because of its unique ability to detect a disturbed molecular pathway through measurements of glucose uptake.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
79
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
3

Relationship

6
4

Authors

Journals

citations
Cited by 60 publications
(79 citation statements)
references
References 71 publications
0
79
0
Order By: Relevance
“…Furthermore, it was not possible to make a quantitative estimate of glycolytic flux from these data. More recently, Brender et al (30) showed that dynamic images of tumor glucose consumption and lactate production could be acquired with nonhyperpolarized 13 C-labeled glucose by using tensor decomposition, which effectively uses all of the signal collected during 90 minutes of data acquisition, to denoise the images and to generate a time series of individual images. However, again there was no quantitative estimate of the glycolytic rate.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, it was not possible to make a quantitative estimate of glycolytic flux from these data. More recently, Brender et al (30) showed that dynamic images of tumor glucose consumption and lactate production could be acquired with nonhyperpolarized 13 C-labeled glucose by using tensor decomposition, which effectively uses all of the signal collected during 90 minutes of data acquisition, to denoise the images and to generate a time series of individual images. However, again there was no quantitative estimate of the glycolytic rate.…”
Section: Discussionmentioning
confidence: 99%
“…Given ongoing efforts to establish robust acquisition and analysis methodologies for clinical 1 H MRS 27 , we expect that qMRS will be easily implemented on 3T and 7T clinical scanners, making it relatively straight-forward to translate to clinical use. It is also possible to further improve qMRS by applying spectral denoising strategies [28][29][30] ( Fig. S6).…”
Section: Discussionmentioning
confidence: 99%
“…Wide clinical implementation of hyperpolarized metabolic imaging may be currently limited by the logistics and cost of equipment, but active clinical studies testing methodological modifications are currently being conducted and could facilitate wider application of metabolic MRI 30,64 . Furthermore, recent improvements in data processing have enabled omission of hyperpolarization for metabolic imaging and could be tested in the setting of GvHD 65,66 .…”
Section: Discussionmentioning
confidence: 99%